270 related articles for article (PubMed ID: 15673597)
21. Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
Ward KW; Stelman GJ; Morgan JA; Zeigler KS; Azzarano LM; Kehler JR; McSurdy-Freed JE; Proksch JW; Smith BR
Drug Metab Dispos; 2004 Feb; 32(2):172-7. PubMed ID: 14744938
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes.
Zhu M; Zhao W; Jimenez H; Zhang D; Yeola S; Dai R; Vachharajani N; Mitroka J
Drug Metab Dispos; 2005 Apr; 33(4):500-7. PubMed ID: 15640381
[TBL] [Abstract][Full Text] [Related]
23. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
Masica AL; Mayo G; Wilkinson GR
Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
[TBL] [Abstract][Full Text] [Related]
24. Potential drug-food interactions with pomegranate juice.
Summers KM
Ann Pharmacother; 2006; 40(7-8):1472-3. PubMed ID: 16804094
[No Abstract] [Full Text] [Related]
25. By the way, doctor. Pomegranate juice is supposed to be a health food, but I've heard that it can interfere with some medications, the way grapefruit juice can. I take Lipitor and wonder if I should be concerned.
Robb-Nicholson C
Harv Womens Health Watch; 2006 Jul; 13(11):8. PubMed ID: 16862703
[No Abstract] [Full Text] [Related]
26. Influence of intravenous methylprednisolone pulse treatment on the disposition of ciclosporin and hepatic CYP3A activity in rats.
Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
J Pharm Pharmacol; 2004 Apr; 56(4):477-83. PubMed ID: 15099443
[TBL] [Abstract][Full Text] [Related]
27. Single-point sampling for assessment of constitutive, induced, and inhibited cytochrome P450 3A activity with alfentanil or midazolam.
Chaobal HN; Kharasch ED
Clin Pharmacol Ther; 2005 Nov; 78(5):529-39. PubMed ID: 16321619
[TBL] [Abstract][Full Text] [Related]
28. White and colored grapefruit juice produce similar pharmacokinetic interactions.
Uesawa Y; Abe M; Mohri K
Pharmazie; 2008 Aug; 63(8):598-600. PubMed ID: 18771009
[TBL] [Abstract][Full Text] [Related]
29. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy.
Garg SK; Kumar N; Bhargava VK; Prabhakar SK
Clin Pharmacol Ther; 1998 Sep; 64(3):286-8. PubMed ID: 9757152
[TBL] [Abstract][Full Text] [Related]
30. Effects of long-term grapefruit juice ingestion on nifedipine pharmacokinetics: induction of rat hepatic P-450 by grapefruit juice.
Mohri K; Uesawa Y; Sagawa Ki
Drug Metab Dispos; 2000 Apr; 28(4):482-6. PubMed ID: 10725318
[TBL] [Abstract][Full Text] [Related]
31. Drug interaction potentials among different brands of grapefruit juice.
Uesawa Y; Mohri K
Pharmazie; 2008 Feb; 63(2):144-6. PubMed ID: 18380401
[TBL] [Abstract][Full Text] [Related]
32. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
Edwards DJ; Bellevue FH; Woster PM
Drug Metab Dispos; 1996 Dec; 24(12):1287-90. PubMed ID: 8971132
[TBL] [Abstract][Full Text] [Related]
33. Risperidone-carbamazepine interactions: is cytochrome P450 3A involved?
Lane HY; Chang WH
J Clin Psychiatry; 1998 Aug; 59(8):430-1. PubMed ID: 9721825
[No Abstract] [Full Text] [Related]
34. Inhibitory effects of citrus fruits on cytochrome P450 3A (CYP3A) activity in humans.
Fujita K; Hidaka M; Takamura N; Yamasaki K; Iwakiri T; Okumura M; Kodama H; Yamaguchi M; Ikenoue T; Arimori K
Biol Pharm Bull; 2003 Sep; 26(9):1371-3. PubMed ID: 12951492
[TBL] [Abstract][Full Text] [Related]
35. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.
Ragueneau-Majlessi I; Levy RH; Bergen D; Garnett W; Rosenfeld W; Mather G; Shah J; Grundy JS
Epilepsy Res; 2004 Nov; 62(1):1-11. PubMed ID: 15519127
[TBL] [Abstract][Full Text] [Related]
36. On the assessment of effects of food on the pharmacokinetics of drugs in early development.
Li Z; Vachharajani NN; Krishna R
Biopharm Drug Dispos; 2002 May; 23(4):165-71. PubMed ID: 12015791
[TBL] [Abstract][Full Text] [Related]
37. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans.
Grenier J; Fradette C; Morelli G; Merritt GJ; Vranderick M; Ducharme MP
Clin Pharmacol Ther; 2006 Mar; 79(3):255-62. PubMed ID: 16513449
[TBL] [Abstract][Full Text] [Related]
38. Dramatic inhibition of amiodarone metabolism induced by grapefruit juice.
Libersa CC; Brique SA; Motte KB; Caron JF; Guédon-Moreau LM; Humbert L; Vincent A; Devos P; Lhermitte MA
Br J Clin Pharmacol; 2000 Apr; 49(4):373-8. PubMed ID: 10759694
[TBL] [Abstract][Full Text] [Related]
39. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp.
Qiu W; Jiang XH; Liu CX; Ju Y; Jin JX
Phytother Res; 2009 Nov; 23(11):1553-8. PubMed ID: 19370549
[TBL] [Abstract][Full Text] [Related]
40. Pomegranate juice does not affect the disposition of simvastatin in healthy subjects.
Park SJ; Yeo CW; Shim EJ; Kim H; Liu KH; Shin JG; Shon JH
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):339-44. PubMed ID: 25720525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
